Appetite suppressants and primary pulmonary hypertension in the United Kingdom
about
Extracts from "Clinical Evidence". Obesity.Managing obesity like any other chronic condition. Long-term therapy may reduce comorbidity as well.Pharmacological treatment of obesity.Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth.Risks associated with herbal slimming remedies.A randomized double-blind placebo-controlled study of the long-term efficacy and safety of diethylpropion in the treatment of obese subjects.
P2860
Appetite suppressants and primary pulmonary hypertension in the United Kingdom
description
1995 nî lūn-bûn
@nan
1995 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
name
Appetite suppressants and primary pulmonary hypertension in the United Kingdom
@ast
Appetite suppressants and primary pulmonary hypertension in the United Kingdom
@en
Appetite suppressants and primary pulmonary hypertension in the United Kingdom
@nl
type
label
Appetite suppressants and primary pulmonary hypertension in the United Kingdom
@ast
Appetite suppressants and primary pulmonary hypertension in the United Kingdom
@en
Appetite suppressants and primary pulmonary hypertension in the United Kingdom
@nl
prefLabel
Appetite suppressants and primary pulmonary hypertension in the United Kingdom
@ast
Appetite suppressants and primary pulmonary hypertension in the United Kingdom
@en
Appetite suppressants and primary pulmonary hypertension in the United Kingdom
@nl
P2093
P2860
P356
P1476
Appetite suppressants and primary pulmonary hypertension in the United Kingdom
@en
P2093
B P Madden
P A Corris
P C Waller
S H Thomas
T W Higenbottam
P2860
P356
10.1136/HRT.74.6.660
P407
P577
1995-12-01T00:00:00Z